24(top 52%)
articles
364(top 48%)
citations
3(top 50%)
★★ articles
0(top 27%)
★★★ articles
2.6(top 19%)
Avg IF
8(top 49%)
H-Index
19(top 44%)
G-Index
21
journals

Most Cited Articles of Lille University of Health and Law in 2017

TitleJournalYearCitations
Dabrafenib plus trametinib in patients with BRAF-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialLancet Oncology, The2017389
Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVIJournal of the American College of Cardiology2017192
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)Annals of Oncology2017148
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialEuropean Journal of Cancer2017146
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 PatientsCirculation2017103
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosisEuropean Respiratory Journal201789
A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicityArchives of Toxicology201771
Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot StudyCanadian Journal of Neurological Sciences201771
Pendred syndromeBest Practice and Research in Clinical Endocrinology and Metabolism201759
Physical activity using wrist-worn accelerometers: comparison of dominant and non-dominant wristClinical Physiology and Functional Imaging201757
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association reportBlood201757
Chemical Evaluation of Electronic Cigarettes: Multicomponent Analysis of Liquid Refills and their Corresponding AerosolsJournal of Analytical Toxicology201754
Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa StudyLeukemia201753
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 CasesClinical Cancer Research201753
Transdermal skin patch based on reduced graphene oxide: A new approach for photothermal triggered permeation of ondansetron across porcine skinJournal of Controlled Release201752
Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphomaAnnals of Oncology201752
AllergoOncology - the impact of allergy in oncology: EAACI position paperAllergy: European Journal of Allergy and Clinical Immunology201750
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myelomaLeukemia201750
Surgical rates in the era of biological therapy: up, down or unchanged?Current Opinion in Gastroenterology201745
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015Anaesthesia, Critical Care & Pain Medicine201743
Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled TrialArthritis Care and Research201738
Cardiopulmonary resuscitation duration and survival in out-of-hospital cardiac arrest patientsResuscitation201737
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myelomaScience Translational Medicine201736
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemiaHaematologica201735
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATERheumatology201734